Allarity Therapeutics, Inc. (ALLR) Financials

ALLR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 32.1 million 28.6 million
March 31, 2026 34.9 million 28.0 million
Dec. 31, 2025 18.3 million 8.4 million
Sept. 30, 2025 20.8 million 8.8 million

ALLR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.6 million 188000
March 31, 2026 -4.6 million 160000
Dec. 31, 2025 -3.3 million 47000
Sept. 30, 2025 -3.4 million 132000

ALLR Net Income

No data available :(

ALLR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 17.0 million - -
March 31, 2026 19.8 million - -
Dec. 31, 2025 14.7 million - -
Sept. 30, 2025 16.9 million - -

ALLR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 15.9 million
March 31, 2026 16.0 million
Dec. 31, 2025 14.4 million
Sept. 30, 2025 14.7 million

ALLR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 1.3 million 1.3 million -
March 31, 2026 64000 1.3 million 1.4 million -
Dec. 31, 2025 - 1.7 million 1.6 million -
Sept. 30, 2025 - 1.2 million 1.3 million -

ALLR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 25000 -26000
Dec. 31, 2025 320000 -
Sept. 30, 2025 - -

ALLR

Price: $0.99

52 week price:
0.77
1.84

Earnings Per Share: -0.80 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 959260

Market Capitalization: 15.8 million

Links: